| Serial Number | 90282216 |
| Word Mark | AMPHIVENA RESTORE |
| Filing Date | Tuesday, October 27, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, February 14, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 18, 2021 |
| Goods and Services | Laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 18, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Amphivena Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Amphivena Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Monday, February 14, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, February 14, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, July 13, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 18, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 18, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 28, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, April 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 12, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 12, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, April 12, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 12, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, April 8, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 8, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, April 8, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, March 26, 2021 | ASSIGNED TO EXAMINER |
| Friday, December 18, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, October 30, 2020 | NEW APPLICATION ENTERED IN TRAM |